Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Testing feedback of treatment data to heart attack care teams

Tests whether sharing treatment data with teams improves care for people having a heart attack.

Key facts

Who runs it
Karl Heinrich Scholz
Where
Hildesheim, GermanySee the site
Trial code
Registry title
Feedback Intervention and Treatment Times in ST- Elevation Myocardial Infarction
Status
Recruiting
People taking part
50,000 people, planned
Started
Oct 2007
Expected to end
Dec 2026
Type of study
Interventional
Treatments tested
  • Data analysis and Feedback
Record updated
30 March 2023

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with a heart attack of the STEMI type who were taken to a heart catheter lab for an emergency procedure to open the blocked artery (primary PCI).

Sex
All sexes can join.
Disease stage
A heart attack with raised ST segments on the heart tracing (STEMI), or a new or probably new left bundle branch block with typical symptoms.

Main reasons for not taking part

  • Heart attack symptoms that lasted longer than 24 hours

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • all patients who received a diagnosis of STEMI* and were transported to the cardiac catheterization laboratory of the primary PCI center with the intention to perform primary PCI; STEMI definition:
  • elevation of the ST-segments of greater than or equal to 0.1 mV in at least two contiguous limb- or precordial leads
  • new or presumable new left bundle branch block in the presence of typical symptoms

Who cannot take part

  • STEMI-patients with duration of infarct-related symptoms longer than 24 hours are excluded

Where in Germany

  • St.Bernward HospitalHildesheim, GermanyContact: Karl H Scholz, MD.Taking people

About the trial

What the trial wants to find out

Part I (Pilot Phase): The purpose of this study is to examine if formalized data assessment and systematic feedback improves treatment times (i.e. contact-to-balloon time and door-to-balloon time) in patients with myocardial infarction with ST-segment elevation (STEMI).

Read full original descriptionShow less

Part II (Implementation Phase): The Purpose is to prospectively investigate if survival can be improved by stringent use of this concept of formalized data analysis and systematic feedback of procedural and clinical data to all participating physicians and other members of the STEMI patients treating personnel.

Part III (Advance Phase): The purpose is to develop, introduce and evaluate prospectively an automated, highly standardized feedback tool informing participating centers on key performance characteristics (procedural and clinical outcomes).

The group in the trial

  • Data FeedbackTreatment being tested

    The intervention is systematic feedback on performance (using predefined quality indicators) to cardiology, ED, and EMS-stakeholders and staff.

    Treatment: Data analysis and Feedback

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Feedback Intervention and Treatment Times in ST- Elevation Myocardial Infarction (FITT-STEMI): A Multicenter Trial Analyzing the Effects of Systematic Data Feedback on Treatment Quality and Survival Rates.
Plain-language title
Testing feedback of treatment data to heart attack care teamsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
30 March 2023